First selective MET inhibitor approved for patients with MET-amplified advanced gastric cancer or gastroesophageal junction adenocarcinoma in ChinaHONG KONG and SHANGHAI and FLORHAM PARK, N.J., July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results